Literature DB >> 2500358

The immunomodulatory effects of interferon-gamma on mature B-lymphocyte responses.

A Jurado1, J Carballido, H Griffel, H K Hochkeppel, G D Wetzel.   

Abstract

Interferon-gamma (IFN-gamma) exerts a broad spectrum of activities which affect the responses of mature B-cells. It strongly inhibits B-cell activation, acts as a B-cell growth factor (BCGF), and also induces final differentiation to immunoglobulin (Ig) production. IFN-gamma is deeply involved in the differential control of isotype expression, as it enhances IgG2a production and suppresses both IgG1 and IgE production. Although it is now possible to draw a general scheme of the effects of IFN-gamma on B-cells, a number of paradoxical results still exist in the field. In this manuscript, different experimental systems are analyzed in an attempt to explain these apparent paradoxes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500358     DOI: 10.1007/bf01990501

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  41 in total

1.  B cell growth factor activity of interferon-gamma. Recombinant human interferon-gamma promotes proliferation of anti-mu-activated human B lymphocytes.

Authors:  S Romagnani; M G Giudizi; R Biagiotti; F Almerigogna; C Mingari; E Maggi; C M Liang; L Moretta
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

Review 2.  Regulation of human B lymphocyte activation, proliferation, and differentiation.

Authors:  D F Jelinek; P E Lipsky
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

Review 3.  Regulation of IgG1 and IgE production by interleukin 4.

Authors:  C M Snapper; F D Finkelman; W E Paul
Journal:  Immunol Rev       Date:  1988-02       Impact factor: 12.988

4.  Induction of resting B cells to DNA synthesis by soluble monoclonal anti-immunoglobulin.

Authors:  M H Julius; C H Heusser; K U Hartmann
Journal:  Eur J Immunol       Date:  1984-08       Impact factor: 5.532

5.  Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.

Authors:  J Ohara; W E Paul
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

6.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

7.  Single cell studies on the role of B-cell stimulatory factor 1 in B-cell activation.

Authors:  M R Alderson; B L Pike; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

8.  Inhibition of B lymphocyte activation by interferon-gamma.

Authors:  D S Reynolds; W H Boom; A K Abbas
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

9.  Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta.

Authors:  E Petit-Koskas; E Génot; D Lawrence; J P Kolb
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

10.  IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.

Authors:  F D Finkelman; I M Katona; T R Mosmann; R L Coffman
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

View more
  11 in total

1.  Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.

Authors:  Avi-Hai Hovav; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice.

Authors:  Jiu ling Wang; Ya qing Qie; Bing dong Zhu; Hong mei Zhang; Ying Xu; Qing zhong Wang; Jia zhen Chen; Wei Liu; Hong hai Wang
Journal:  Med Microbiol Immunol       Date:  2008-05-20       Impact factor: 3.402

3.  Submicroscopic Plasmodium infection during pregnancy is associated with reduced antibody levels to tetanus toxoid.

Authors:  C Álvarez-Larrotta; O M Agudelo; Y Duque; K Gavina; S K Yanow; A Maestre; J Carmona-Fonseca; E Arango
Journal:  Clin Exp Immunol       Date:  2018-10-19       Impact factor: 4.330

Review 4.  Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity.

Authors:  Elise Alspach; Danielle M Lussier; Robert D Schreiber
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-03-01       Impact factor: 10.005

5.  High-dose interferon-gamma alters the distribution of B lymphocytes and macrophages in rat spleen and lymph nodes.

Authors:  B Steiniger; P H van der Meide
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

6.  The tick salivary protein, Salp15, inhibits the development of experimental asthma.

Authors:  Sara A Paveglio; Jenna Allard; Jana Mayette; Laurie A Whittaker; Ignacio Juncadella; Juan Anguita; Matthew E Poynter
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

7.  IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis.

Authors:  Juan Liu; Erin Harberts; Antonella Tammaro; Nicholas Girardi; Renata B Filler; Rita Fishelevich; Angela Temann; Paula Licona-Limón; Michael Girardi; Richard A Flavell; Anthony A Gaspari
Journal:  J Invest Dermatol       Date:  2014-01-31       Impact factor: 8.551

8.  TLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines.

Authors:  Tomer Israely; Sharon Melamed; Hagit Achdout; Noam Erez; Boaz Politi; Trevor Waner; Shlomo Lustig; Nir Paran
Journal:  PLoS One       Date:  2014-10-28       Impact factor: 3.240

9.  IFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection.

Authors:  Elizabeth K Naglak; Sandra G Morrison; Richard P Morrison
Journal:  Infect Immun       Date:  2016-09-06       Impact factor: 3.441

10.  OVA-Experienced CD4+ T Cell Transfer and Chicken Protein Challenge Affect the Immune Response to OVA in a Murine Model.

Authors:  Ewa Fuc; Dagmara Złotkowska; Ewa Wasilewska; Barbara Wróblewska
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.